Strategies for modifying drug residence time and ocular bioavailability to decrease treatment frequency for back of the eye diseases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Strategies for modifying drug residence time and ocular bioavailability to decrease treatment frequency for back of the eye diseases

Published:2018-12-07 Issue:1 Volume:16 Page:43-57
ISSN:1742-5247
Container-title:Expert Opinion on Drug Delivery
language:en
Short-container-title:Expert Opinion on Drug Delivery

Author:

Shatz Whitney¹²,Aaronson Jeffrey³,Yohe Stefan³,Kelley Robert F.³,Kalia Yogeshvar N.²

Affiliation:

1. Department of Protein Chemistry, Genentech, South San Francisco, CA, USA

2. School of Pharmaceutical Sciences, University of Geneva & University of Lausanne, Geneva, Switzerland

3. Department of Drug Delivery, Genentech, South San Francisco, CA, USA

Funder

Y Kalia is an employee of, and was funded by, the University of Geneva

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425247.2019.1553953

Reference145 articles.

1. Ranibizumab for exudative AMD in a clinical setting: differences between 2007 and 2010

2. Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration

3. Ranibizumab Prefilled Syringes: Benefits of Reduced Syringe Preparation Times and Less Complex Preparation Procedures

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review on revolutionizing ophthalmic therapy: Unveiling the potential of chitosan, hyaluronic acid, cellulose, cyclodextrin, and poloxamer in eye disease treatments;International Journal of Biological Macromolecules;2024-07

2. Polymeric microneedles for the eye: An overview of advances and ocular applications for minimally invasive drug delivery;European Journal of Pharmaceutics and Biopharmaceutics;2024-04

3. Recent advances in the treatment and delivery system of diabetic retinopathy;Frontiers in Endocrinology;2024-02-15

4. Smart design of patient-centric long-acting products: from preclinical to marketed pipeline trends and opportunities;Expert Opinion on Drug Delivery;2022-08-02

5. Penetrating-peptide-mediated non-invasive Axitinib delivery for anti-neovascularisation;Journal of Controlled Release;2022-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3